flops

BridgeBio Pharma (BBIO) stated Monday its Pfizer (PFE)-rivaling coronary heart illness drug unsuccessful in a late-stage examination — and BBIO inventory crashed to a file low. X The company examined its drug in sufferers with amyloid cardiomyopathy, a problem in which irregular protein builds up on the heart. Just after […]